|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Michelotti GA, Machado MV and Diehl AM:
NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol.
10:656–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu JJ, Xiao W, Dong SL, Liang HF, Zhang
ZW, Zhang BX, Huang ZY, Chen YF, Zhang WG, Luo HP, et al: Effect of
surgical liver resection on circulating tumor cells in patients
with hepatocellular carcinoma. BMC Cancer. 18:8352018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu X, Jiang J, Xu Q, Ni C, Yang L and
Huang D: A systematic review of long noncoding RNAs in
hepatocellular carcinoma: molecular mechanism and clinical
implications. BioMed Res Int. 2018:81262082018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhan A, Soleimani M, Mandal SS and Long
Noncoding RNA: Long noncoding RNA and cancer: A new paradigm.
Cancer Res. 77:3965–3981. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang X, Yao B, Niu Y, Chen T, Mo H, Wang
L, Guo C and Yao D: Hypoxia-induced lncRNA EIF3J-AS1 accelerates
hepatocellular carcinoma progression via targeting
miR-122-5p/CTNND2 axis. Biochem Biophys Res Commun. 518:239–245.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng J, Yang G, Liu Y, Gao Y, Zhao M, Bu
Y, Yuan H, Yuan Y, Yun H, Sun M, et al: LncRNA PCNAP1 modulates
hepatitis B virus replication and enhances tumor growth of liver
cancer. Theranostics. 9:5227–5245. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang W, Wu Y, Hou B, Wang Y, Deng D, Fu Z
and Xu Z: A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives
tumor growth and metastasis in hepatocellular carcinoma through the
Wnt/β-catenin pathway. Mol Oncol. 13:2194–2210. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ji D, Hu G, Zhang X, Yu T and Yang J: Long
non-coding RNA DSCAM-AS1 accelerates the progression of
hepatocellular carcinoma via sponging miR-338-3p. Am J Transl Res.
11:4290–4302. 2019.PubMed/NCBI
|
|
10
|
Pang Q, Ge J, Shao Y, Sun W, Song H, Xia
T, Xiao B and Guo J: Increased expression of long intergenic
non-coding RNA LINC00152 in gastric cancer and its clinical
significance. Tumour Biol. 35:5441–5447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li M, Wang Q, Xue F and Wu Y: lncRNA-CYTOR
Works as an oncogene through the CYTOR/miR-3679-5p/MACC1 axis in
colorectal cancer. DNA Cell Biol. 38:572–582. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Li M, Yu H and Piao H: lncRNA CYTOR
promotes tamoxifen resistance in breast cancer cells via sponging
miR 125a 5p. Int J Mol Med. 45:497–509. 2020.PubMed/NCBI
|
|
13
|
Zhang J and Li W: Long noncoding RNA CYTOR
sponges miR-195 to modulate proliferation, migration, invasion and
radiosensitivity in nonsmall cell lung cancer cells. Biosci Rep.
38:382018. View Article : Google Scholar
|
|
14
|
Thuluvath PJ, To C and Amjad W: Role of
locoregional therapies in patients with hepatocellular cancer
awaiting liver transplantation. Am J Gastroenterol. 116:57–67.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ruggieri A, Barbati C and Malorni W:
Cellular and molecular mechanisms involved in hepatocellular
carcinoma gender disparity. Int J Cancer. 127:499–504. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Böhmdorfer G and Wierzbicki AT: Control of
chromatin structure by long noncoding RNA. Trends Cell Biol.
25:623–632. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bonasio R and Shiekhattar R: Regulation of
transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Yu H, Sun W, Kong J, Zhang L, Tang
J, Wang J, Xu E, Lai M and Zhang H: The long non-coding RNA CYTOR
drives colorectal cancer progression by interacting with NCL and
Sam68. Mol Cancer. 17:1102018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yue B, Liu C, Sun H, Liu M, Song C, Cui R,
Qiu S and Zhong M: A Positive Feed-Forward Loop between
LncRNA-CYTOR and Wnt/β-Catenin Signaling Promotes Metastasis of
Colon Cancer. Mol Ther. 26:1287–1298. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang J, Wei X, Liu Z, Cao D, Tang Y, Zou
Z, Zhou C and Lu Y: Long noncoding RNA CYTOR in cancer: A TCGA data
review. Clin Chim Acta. 483:227–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ,
Wang CY, Zhang HM, Zhang RX, Zhang JJ, et al: LncRNA HULC enhances
epithelial-mesenchymal transition to promote tumorigenesis and
metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1
signaling pathway. Oncotarget. 7:42431–42446. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Chen G, Yan Y and Fan Q: CASC15
promotes epithelial to mesenchymal transition and facilitates
malignancy of hepatocellular carcinoma cells by increasing TWIST1
gene expression via miR-33a-5p sponging. Eur J Pharmacol.
860:1725892019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Zhu Z, Huang S, Zhao Q, Huang C,
Tang Y, Sun C, Zhang Z, Wang L, Chen H, et al: lncRNA XIST
regulates proliferation and migration of hepatocellular carcinoma
cells by acting as miR-497-5p molecular sponge and targeting PDCD4.
Cancer Cell Int. 19:1982019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hua S, Quan Y, Zhan M, Liao H, Li Y and Lu
L: miR-125b-5p inhibits cell proliferation, migration, and invasion
in hepatocellular carcinoma via targeting TXNRD1. Cancer Cell Int.
19:2032019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Wang Q, Wen R, Liang J, Zhong X,
Yang W, Su D and Tang J: MiR-138 inhibits cell proliferation and
reverses epithelial-mesenchymal transition in non-small cell lung
cancer cells by targeting GIT1 and SEMA4C. J Cell Mol Med.
19:2793–2805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Q, Wang Y, Lu X, Zhao Z, Zhu L, Chen
S, Wu Q, Chen C and Wang Z: MiR-125b regulates
epithelial-mesenchymal transition via targeting Sema4C in
paclitaxel-resistant breast cancer cells. Oncotarget. 6:3268–3279.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y and Huang S: Up-regulation of
miR-125b reverses epithelial-mesenchymal transition in
paclitaxel-resistant lung cancer cells. Biol Chem. Aug
20–2015.(Epub ahead of print). doi: 10.1515/hsz-2015-0153.
View Article : Google Scholar
|
|
32
|
Yang J, Zeng Z, Qiao L, Jiang X, Ma J,
Wang J, Ye S, Ma Q, Wei J, Wu M, et al: Semaphorin 4C Promotes
macrophage recruitment and angiogenesis in breast cancer. Mol
Cancer Res. 17:2015–2028. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song J and Li Y: miR-25-3p reverses
epithelial-mesenchymal transition via targeting Sema4C in
cisplatin-resistance cervical cancer cells. Cancer Sci. 108:23–31.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu J, Lin Y, Li F, Ye H, Zhou R, Jin Y, Li
B, Xiong X and Cheng N: MiR-205 suppresses tumor growth, invasion,
and epithelial-mesenchymal transition by targeting SEMA4C in
hepatocellular carcinoma. FASEB J. May 25–2018.doi:
10.1096/fj.201800113R.
|
